Response To: ‘Clinical Benefit of Vedolizumab on Articular Manifestations in Patients With Active Spondyloarthritis Associated With Inflammatory Bowel Disease’ by Orlando Et Al
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2016-211045
Full Text
Open PDFAbstract
Available in full text
Date
February 9, 2017
Authors
Publisher
BMJ